Sign In
Buy CLOV
$4.27
-0.0600 (-1.39%)
At Close: Aug 04, 2026
Clover Health Investments, Corp. (CLOV) Q1 2024 Earnings Call Transcript
08:14pm, Tuesday, 07'th May 2024
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Ryan Schmidt - IR Andrew Toy - CEO Terrence Ronan - Interim CFO Conference
Clover Health Investments, Corp. (CLOV) Reports Q1 Loss, Tops Revenue Estimates
07:06pm, Tuesday, 07'th May 2024
Clover Health Investments, Corp. (CLOV) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.15 per share a year ago.
3 Healthcare Stocks to Sell in May Before They Crash & Burn
11:03am, Tuesday, 07'th May 2024
For many investors, the concept of putting money into healthcare stocks to sell them at a future date might seem like a safe investment. After all, almost every person in the United States is dependen
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Tuesday, 30'th Apr 2024
FRANKLIN, Tenn., April 30, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement technology company committed to bringing
Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024
04:05pm, Tuesday, 23'rd Apr 2024
FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first
Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer
04:05pm, Monday, 22'nd Apr 2024
FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company,
Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions
04:30pm, Thursday, 04'th Apr 2024
FRANKLIN, Tenn., April 04, 2024 (GLOBE NEWSWIRE) -- As previously disclosed, most recently in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and in its Quarterly Report on
3 Under-the-Radar Stocks to Transform $10K into $100K by 2028
04:30pm, Wednesday, 20'th Mar 2024
Numbers frequently take center stage in the stock market's maze. However, every figure has a story of strategy, ingenuity, and resiliency behind it.
Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness
09:00am, Tuesday, 19'th Mar 2024
Partnership aims to improve outcomes through increased support to underserved and at-risk patient populations through Clover's home-based care model Partnership aims to improve outcomes through increa
Clover Health Investments, Corp. (CLOV) Q4 2023 Earnings Call Transcript
06:58pm, Tuesday, 12'th Mar 2024
Clover Health Investments, Corp. (CLOV) Q4 2023 Earnings Call Transcript
Full-year 2023 Insurance MCR improved to 81.2% and fourth quarter MCR to 82.4% Company improves full-year 2023 Net Loss by $126.2 million and full-year Adjusted EBITDA by $245.7 million year-over-year
Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage
04:05pm, Thursday, 07'th Mar 2024
Mr. Thornton brings a decade of Medicare Advantage leadership experience Mr. Thornton brings a decade of Medicare Advantage leadership experience
Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
04:05pm, Monday, 26'th Feb 2024
FRANKLIN, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report fourth
3 Under-the-Radar Penny Stocks With 1,000% Growth Potential by 2026
02:05pm, Tuesday, 20'th Feb 2024
In the stock market, identifying penny stocks with massive growth potential is similar to walking on a rope between two skyscrapers. Penny stocks offer high potential returns.
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 16'th Feb 2024
FRANKLIN, Tenn., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”) announced today that effective February 16, 2024, the Talent and
